Description

Description

Tagipmet XR (50mg/1000mg) is a fixed-dose combination medicine manufactured by Highnoon Laboratories, formulated with Sitagliptin 50mg and extended-release Metformin 1000mg in each tablet. This pack contains 20 tablets and represents the higher-strength Metformin variant within the Tagipmet XR range, intended for adults with type 2 diabetes mellitus who require a more substantial Metformin dose alongside the DPP-4 inhibiting action of Sitagliptin, delivered through a once-daily extended-release formulation. This combination is typically prescribed for patients who have already been stabilized on both individual components at these respective doses, or for those whose physician determines that this stronger, more convenient once-daily option is appropriate. Sitagliptin works by increasing levels of natural hormones that prompt the pancreas to release more insulin when blood sugar is high while also reducing glucose production by the liver, offering a relatively gentle safety profile with a lower likelihood of causing significant drops in blood sugar on its own. The extended-release Metformin component gradually releases the medicine over the day, supporting steady blood sugar control while potentially reducing the gastrointestinal discomfort associated with immediate-release versions. Together, this combination is intended to offer stronger, more comprehensive glycemic support with a simplified once-daily regimen. Tagipmet XR should always be used as part of a broader diabetes management plan that includes appropriate diet, physical activity, and regular blood sugar monitoring, under the ongoing supervision of a qualified healthcare provider.

Ingredients

Each tablet of Tagipmet XR (50/1000mg) contains two active pharmaceutical ingredients: Sitagliptin 50mg, a DPP-4 inhibitor that supports insulin release and reduces liver glucose production, and Metformin Hydrochloride 1000mg in extended-release form, a biguanide-class antidiabetic agent that reduces hepatic glucose output and enhances insulin sensitivity. The tablet also contains specialized extended-release excipients and film-coating agents that regulate the gradual release of Metformin, along with standard pharmaceutical binders that support overall tablet stability.

Dosage Form

Tagipmet XR (50/1000mg) is available as an oral extended-release film-coated tablet, delivering a combined strength of 50mg Sitagliptin and 1000mg extended-release Metformin per tablet. The pack contains 20 tablets, formulated for once-daily administration and representing the higher-dose option within the Tagipmet XR range, as directed by a treating physician.

Uses

Tagipmet XR (50/1000mg) is used to help improve blood sugar control in adults with type 2 diabetes mellitus who require a higher dose of Metformin in combination with Sitagliptin, delivered through a once-daily extended-release tablet. It is often prescribed for patients who need further glycemic improvement beyond what lower-strength combinations provide, or for those who prefer the convenience and reduced gastrointestinal impact of the extended-release formulation. It may also be used alongside other antidiabetic medicines as part of a comprehensive treatment strategy. This medicine is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

How to Use

Tagipmet XR tablets are typically taken once daily with the evening meal, or as otherwise directed by a doctor, to support consistent absorption and minimize gastrointestinal discomfort. The tablet must be swallowed whole with a glass of water and should never be crushed, split, or chewed, as this would disrupt the extended-release mechanism and cause the medicine to be released too rapidly. It is not unusual to notice a tablet-shaped residue in the stool, which reflects the outer shell of the extended-release system passing through the digestive tract after the active ingredients have been absorbed. Dosage and treatment duration should strictly follow the prescribing physician’s instructions, and if a dose is missed, it should be taken as soon as remembered unless it is close to the time of the next scheduled dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

Tagipmet XR (50/1000mg) may cause side effects in some individuals, and the higher Metformin strength may make gastrointestinal effects slightly more noticeable, especially when treatment is first started. Commonly reported effects include nausea, mild diarrhea, or stomach discomfort, along with headache and upper respiratory symptoms linked to the Sitagliptin component. Some patients may also experience a metallic taste or mild dizziness. In rare cases, more serious effects such as lactic acidosis (associated with Metformin), pancreatitis, or severe allergic reactions (associated with Sitagliptin) may occur, and immediate medical attention should be sought if symptoms such as severe abdominal pain, unusual fatigue, difficulty breathing, or persistent vomiting develop.

Pregnancy & Breastfeeding

Tagipmet XR (50/1000mg) is generally not recommended during pregnancy. While Metformin has been used in select pregnancy-related situations under close medical supervision, the safety of Sitagliptin during pregnancy has not been well established, and insulin is typically preferred for blood sugar management during this period. Women who are pregnant, planning pregnancy, or suspect they may be pregnant should inform their doctor immediately. The safety of this combination during breastfeeding has not been well established, and alternative treatment options are usually considered for nursing mothers. Any use during pregnancy or breastfeeding should be decided only in consultation with a qualified healthcare provider.

Storage Instructions

Tagipmet XR tablets should be stored at room temperature, in a cool, dry place away from direct sunlight, heat, and excess moisture. Tablets should be kept in their original packaging until ready for use to protect the extended-release coating from environmental exposure. Store out of reach of children and pets, and do not use the medication beyond its printed expiry date. Unused or expired tablets should be disposed of responsibly according to local pharmaceutical disposal guidelines, rather than discarded with regular household waste.

FAQs

How is the 1000mg version different from the 500mg Tagipmet XR?
The 1000mg strength delivers a higher dose of extended-release Metformin, intended for patients who need more substantial glucose control than the lower-strength combination provides, as determined by their doctor.

Can I switch directly from a lower Tagipmet XR strength to this one?
Any change in strength should only be made under a doctor’s supervision, as it may require monitoring of blood sugar response and kidney function.

Why is once-daily dosing possible with this tablet?
The extended-release Metformin component gradually releases the medicine over the day, allowing for once-daily dosing instead of the multiple daily doses typically needed with immediate-release Metformin.

Do I need extra monitoring at this higher strength?
Yes, your doctor may recommend periodic monitoring of kidney function, blood sugar levels, and overall response while you are on the higher-strength combination.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.